Private
The Department of Homeland Security’s Science and Technology Directorate (S&T) recently awarded CrowdVision Ltd. $160,902 to develop an airport passenger counting and measuring system for U.S. Customs and Border Protection (CBP).
Funding is for phase one of the project.
The company, a... Read More »
The Coalition of Epidemic Preparedness Innovations (CEPI) issued a call Tuesday for funding applications for platforms capable of developing any number of vaccines to respond to as-yet-unknown emerging infectious diseases and unknown pathogens.
Such pathogens, collectively labeled Disease X,... Read More »
A model created by the University College London could be used to predict the next Ebola outbreak by tracking how changes to ecosystems combined with human societies affect the disease’s spread.
The model takes into account factors such as human population, land use, and the impact of climate.... Read More »
Oshkosh Defense recently unveiled the new Light Combat Tactical All-Terrain Vehicle Command and Control (L-ATV C2) in addition to displaying a series of Joint Light Tactical Vehicles (JLTV).
The display occurred during the Association of the United States Army (AUSA) National Conference in... Read More »
Model-based predictions of mosquito species distribution need to be improved in many parts of the country, researchers at the University of Colorado Boulder found.
Researchers assessed and combined previously developed computational models to generate new predictions of where Aedes aegypti and... Read More »
Coppell, Texas-based QED Secure Solutions has secured $200,000 in Department of Homeland Security (DHS) funding to field test a secure trust anchor for the Internet of Things (IoT).
The funding allotment via DHS’s Science and Technology Directorate (S&T) is in conjunction with S&T’s Silicon... Read More »
The World Health Organization (WHO) made $14 billion in funding commitments for the Global Fund, which was established to fight HIV, tuberculosis (TB), and malaria.
The funding commitment, announced at the Global Fund’s Sixth Replenishment Conference in Lyon, France, will be spread over three... Read More »
In an effort to enhance support for its development, the European Committee for Medicinal Products for Human Use (CHMP) granted priority medicine (PRIME) designation in September to a new chikungunya virus vaccine candidate developed by Emergent BioSolutions Inc.
“Emergent is pleased to... Read More »
While the bacteria listeria and the associated infection known as listeriosis has been well known for decades, an international research team recently discovered the most virulent species to date, able to infect and kill humans and animals.
This discovery was isolated in China, by scientists... Read More »
Shipbuilder Fincantieri Marinette Marine and Lockheed Martin recently held a ceremony in Marinette, Wis., to commemorate the start of construction for Littoral Combat Ship (LCS) 27, the future USS Nantucket.
"LCS' built-in flexibility makes it unlike any other Navy ship in the water today," Joe... Read More »
Doha, Qatar, served as the site of a training initiative focusing on addressing risks arising from chemical accidents and the potential misuse of toxic chemicals in ports and maritime venues.
“We aim to raise global standards and set norms for the safety, security, and efficiency of ports and... Read More »
A U.S. tuberculosis vaccination trial utilizing edible sensor technology has reportedly cured 100 percent of participants, leading researchers to suggest that the technology could be a “game changer” in high-risk countries.
A part of Wirelessly Observed Therapy (WOT), the ingestible sensor... Read More »
U.S. Sen. Chris Murphy (D-CT) recently toured the Connecticut Agricultural Experiment Station mosquito lab to learn more about research into Eastern Equine Encephalitis (EEE).
The lab tracks and researches vector-borne diseases, and in 2017, received a five-year, $10 million grant from the... Read More »
The National Threat Initiative (NTI) worked with hospitals, research universities, and other stakeholders to prepare a report with effective and secure solutions to support Congressional efforts to eliminate cesium-137 from facilities around the United States.
The report -- Preventing a Dirty... Read More »
The Department of Homeland Security’s Science and Technology Directorate (S&T) awarded $199,680 to a firm to address security threats to connected devices.
The award went to Bastille Networks of Atlanta, Ga., for its Internet of Things (IoT) security solution that gives system administrators... Read More »
FLIR Systems has reached an agreement to acquire Aria Insight’s Intellectual property (IP) and certain operating assets.
Aria, which was previously known as CyPhy Works, Inc., pioneered the development of tethered small unmanned aerial systems (sUAS) and developed the Persistent Aerial... Read More »
The Infectious Diseases Society of America (IDSA) this week named Dr. Thomas File, Jr. as its newest president, along with five new board members.
File intends to lead the organization in a fight against antimicrobial resistance, developing relationships with state and regional infectious... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) awarded the Albert B. Sabin Vaccine Institute Inc. of Washington, D.C., with about $20.5 million to develop vaccines against Marburg virus and Sudan ebolavirus infections.
Both diseases are caused by the same family of viruses... Read More »
Raytheon Rheinmetall Land Systems, a joint venture of Raytheon Company and Rheinmetall Land Systems, selected Monday Textron Systems to produce the chassis the Lynx Infantry Fighting Vehicle.
The joint venture is looking to offer Lynx to meet the Army's requirement for an Optionally Manned... Read More »
The U.S. Food and Drug Administration (FDA) last week approved Bavarian Nordic to market a new, alternative smallpox vaccine known as JYNNEOS.
JYNNEOS is a live, non-replicating vaccine specifically made for adults. It is an alternative to the existing ACAM2000, which though licensed, cannot be... Read More »
The National Institute of Allergy and Infectious Diseases (NIAID) is launching a network of research centers that will work to develop better influenza vaccines.
NIAID – which is part of the National Institutes of Health -- will provide up to $51 million in funding for the initiative, called... Read More »
The National Institute on Drug Abuse (NIDA) awarded Emergent BioSolutions a $6.3 million research grant for further development of the company’s treatment for opioid addiction.
Specifically, the funding is for the continued development of AP007, Emergent’s sustained-release nalmefene... Read More »
The federal government needs to take a public-health approach for at-risk individuals and strengthen partnerships with civilian researchers to combat the rise of violent far-right terrorism, according to William Braniff, a terrorism expert.
Braniff recently testified to the U.S. Senate Committee... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) awarded a $67 million contract to BioFactura for the advanced development of its Smallpox Biodefense Therapeutic to treat smallpox.
While smallpox was declared eradicated in 1980, the threat of bioterrorism remains. To fill the... Read More »
Vienna, Austria-based Danube Tech GmbH has secured a $143,478 Department of Homeland Security (DHS) Science and Technology Directorate (S&T) contract to develop blockchain security technology.
The award is funded through S&T’s Silicon Valley Innovation Program (SVIP) Other Transaction... Read More »
Under a $30 million contract with the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH), three institutions have been selected to create new centers of immunology research to advance tuberculosis (TB) vaccine development.
The three... Read More »
Scientists may have changed the way Chikungunya vaccines can be designed, produced, and stored, with the creation of a new type of synthetic vaccine that can be stored at warmer temperatures without the need for refrigeration.
The results of the vaccine study, published in Science Advances... Read More »
The Department of Defense’s Medical CBRN Defense Consortium (MCDC) awarded $20 million to Emergent BioSolutions Inc. for the development of an auto-injector to treat nerve agent-induced seizures.
The device, which will contain diazepam (5 mg/mL), is being designed for intramuscular... Read More »
The U.S. Food and Drug Administration (FDA) approved the vaccine Jynneos to treat smallpox and monkeypox in adults.
It is the only currently FDA-approved vaccine for this disease.
“Following the global Smallpox Eradication Program, the World Health Organization certified the eradication of... Read More »
Lockheed Martin officials said flight tests of the firm’s Sikorsky HH-60W Combat Rescue Helicopter have determined the aircraft’s new tactical mission kit operates as designed, ensuring seamless transitioning to evaluation.
“This tactical mission kit leverages the knowledge we’ve gained... Read More »
One of the largest research contracts ever awarded to the University of Maryland School of Medicine (UMSOM) was announced by the National Institute of Allergy and Infectious Diseases (NIAID) this week, to the potential tune of more than $200 million over the next seven years.
Initially, the... Read More »
The Sept. 14 gas explosion that stoked a fire at a Russian bioweapons facility in Siberia where viruses and bacteria including smallpox, Ebola and anthrax are stored reminded the world that humans are only one catastrophic biological event away from a pandemic that could kill tens of millions of... Read More »
Proposed funding allocations by the Senate Appropriations Committee address some of the most urgent threats to public and individual, the Infectious Diseases Society of America said.
The bill’s allotment of $168.5 million for the U.S. Centers for Disease Control and Prevention’s (CDC)... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) intends to provide $14 million and expertise support for the advanced development of an investigational Ebola treatment being pursued by Ridgeback Biotherapeutics of Miami.
Ridgeback is manufacturing the therapeutic drug known as... Read More »
There’s a new word on the street that packs a lot of punch: cyberbiosecurity, which is introducing a host of new multilayered threats to biodefense.
Members of the newly named Bipartisan Commission on Biodefense — formerly the Blue Ribbon Study Panel on Biodefense — last week sought a... Read More »
